Two distinct prescription medications carry imprints containing “MP 9” or “M P9”. Depending on the spacing, color, and shape, the physical tablet corresponds to either Pantoprazole Sodium Delayed-Release 40 mg (M P9) or Atenolol 25 mg (MP 9).
Primary Identification: Pantoprazole Sodium 40 mg (M P9)
The imprint M P9 (with a space between M and P) represents a delayed-release tablet of Pantoprazole Sodium 40 mg, a prescription proton pump inhibitor (PPI).
Physical Property – Specification
- Active Ingredient – Pantoprazole Sodium (40 mg)
- Imprint Code –
M P9 - Color – Yellow
- Shape – Oval (11 mm)
- Coating – Delayed-release / Enteric-coated
- Drug Class – Proton Pump Inhibitor (PPI)
- Manufacturer/Supplier – Matrix Laboratories / Mylan
Mechanism of Action
Pantoprazole works by blocking gastric acid production at the final stage of secretion:
- ATPase Inhibition: Pantoprazole is a substituted benzimidazole that accumulates in the acidic environment of the parietal cell secretory canaliculi.
- Irreversible Binding: It binds covalently to the proton pump ATPase enzyme system, inhibiting both basal and stimulated gastric acid secretion regardless of the stimulus (histamine, acetylcholine, or gastrin).
Indications & Dosage
- Erosive Esophagitis (GERD): 40 mg once daily for up to 8 weeks.
- Maintenance of Healing in Erosive Esophagitis: 40 mg once daily.
- Zollinger-Ellison Syndrome: Starting at 40 mg twice daily, adjusted up to 240 mg daily as clinically indicated.
- Administration Rule: Must be swallowed whole with or without food. Do not crush, split, or chew the tablet, as breaking the enteric coating exposes the active drug to stomach acid, destroying it before it can be absorbed in the intestine.
Side Effects
Common Side Effects:
- Headache, diarrhea, nausea, abdominal pain, flatulence, vomiting, and dizziness.
Serious Side Effects:
- Clostridioides difficile–associated diarrhea (persistent severe watery stool).
- Bone fractures (hip, wrist, spine) with high-dose or long-term use . (> 1 year)
- Vitamin deficiency with long-term therapy (>3 years).
- Hypomagnesemia (low blood magnesium levels) following prolonged use.
- Cutaneous or systemic Lupus Erythematosus flare-ups.
Precautions & Drug Interactions
- Methotrexate: Concomitant use with high-dose methotrexate can increase methotrexate serum levels, leading to severe toxicity.
- HIV Protease Inhibitors: Significantly reduces the absorption of antiretroviral drugs like atazanavir and nelfinavir.
- Clopidogrel & Iron Supplements: Reduced gastric acidity may lower the systemic exposure or absorption of medications requiring an acidic environment (e.g., ketoconazole, iron salts).
Secondary Identification: Atenolol 25 mg (MP 9)
If the tablet is white, round, and imprinted MP 9 (without a space), it is Atenolol 25 mg, manufactured by Mutual Pharmaceutical Company.
Physical Property – Specification
- Active Ingredient – Atenolol (25 mg)
- Imprint Code –
MP 9 - Color – White
- Shape – Round (6 mm)
- Drug Class – Cardioselective Adrenergic Blocker
Mechanism of Action
- Selective Blockade: Atenolol selectively adrenergic receptors located primarily in heart tissue.
- Hemodynamic Effects: Reduces heart rate, cardiac output, myocardial contractility, and blood pressure while decreasing oxygen demand by the myocardium.
Indications & Dosage
- Hypertension (High Blood Pressure): 25 mg to 50 mg once daily, titrated up to 100 mg daily if needed.
- Angina Pectoris: 50 mg once daily, increasing to 100 mg for symptom control.
- Post-Myocardial Infarction: Administered following acute heart attack stabilization to improve survival outcomes.
Side Effects & Warnings
- Common Side Effects: Bradycardia (slow heart rate), cold extremities, fatigue, dizziness, hypotension, and lethargy.
- Black Box Warning: Abrupt Discontinuation. Sudden withdrawal of beta-blockers in patients with coronary artery disease can precipitate severe angina exacerbation, myocardial infarction, or ventricular arrhythmias. Dosage must be gradually tapered under medical supervision.
- Precautions: Use with caution in patients with asthma/COPD (may induce bronchospasm at higher doses), diabetes (can mask hypoglycemia symptoms like tachycardia), or heart failure.